Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

J Klubo-Gwiezdzinska, D Van Nostrand… - The Journal of …, 2011 - academic.oup.com
Background: The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine (131I) therapy. The prescribed …
被引用次数：122 相关文章

Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer.

J Klubo-Gwiezdzinska, D Van Nostrand… - The Journal of …, 2011 - europepmc.org
Background The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine ((131) I) therapy. The prescribed …

[引用][C] Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

J KLUBO-GWIEZDZINSKA… - The Journal of …, 2011 - pascal-francis.inist.fr
Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of
Differentiated Thyroid Cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[HTML] nih.gov

[HTML][HTML] Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

J Klubo-Gwiezdzinska, D Van Nostrand… - The Journal of …, 2011 - ncbi.nlm.nih.gov
Background: The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine (131 I) therapy. The prescribed …

Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer

J Klubo-Gwiezdzinska, D Van Nostrand… - Journal of Clinical …, 2011 - hero.epa.gov
BACKGROUND: The optimal management of high-risk patients with differentiated thyroid
cancer (DTC) consists of thyroidectomy followed by radioiodine ((131) I) therapy. The …

Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

J Klubo-Gwiezdzinska, D Van Nostrand… - The Journal of Clinical …, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background:</jats: title>< jats: p>
The optimal management of high-risk patients with differentiated thyroid cancer (DTC) …

Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer

J Klubo-Gwiezdzinska… - The Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine ((131) I) therapy. The prescribed …

[引用][C] Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer.

J Klubo-Gwiezdzinska… - Journal of Clinical …, 2011 - hsrc.himmelfarb.gwu.edu
"Efficacy of dosimetric versus empiric prescribed activity of 131I for " by J Klubo-Gwiezdzinska,
D Van Nostrand et al. Home Search Browse Collections My Account About DC Network Digital …
[PDF] semanticscholar.org

[PDF][PDF] Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer

J Klubo-Gwiezdzinska, D Van Nostrand, F Atkins… - 2011 - pdfs.semanticscholar.org
Background: The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine (131I) therapy. The prescribed …

Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer.

J Klubo-Gwiezdzinska, D Van Nostrand… - The Journal of …, 2011 - europepmc.org
Background The optimal management of high-risk patients with differentiated thyroid cancer
(DTC) consists of thyroidectomy followed by radioiodine ((131) I) therapy. The prescribed …